Australia's most trusted
source of pharma news
Posted 1 May 2026 AM
The Department of Health, Disability, and Ageing has released its draft Cost Recovery Implementation Statement detailing how much submission fees will rise in the next financial year.
The PBAC expects to evaluate 361 submissions over the course of the next financial year, with an estimated cost to sponsors of $26.96 million. It expects 81 positive recommendation pathways to cost $4.39 million, 639 PBS list management activities to cost $3.46 million, and 5,350 PBS list regulatory activities to cost $5.96 million.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.